$レゾリュート(RZLT.US)$Moomoo 24/7· 1 min ago Rezolute Has Initiated SunRIZE Phase 3 Study Of RZ358 In Patients With Congenital Hyperinsulinism; The First Clinical Site Has Now Been Activated Outside US; Additional Sites Are Being Activated Over The Coming Weeks And Into The Beginning Of 2024
$レゾリュート(RZLT.US)$The European Medicines Agency Has Granted Priority Medicines (PRIME) Eligibility To Rezolute's Rz358 For The Treatment Of Congenital Hyperinsulinism
レゾリュートに関するコメント
読み込み中...
Hmm?
読み込み中...
Some Top Movers 🚨 3/8/2024
Update
Rezolute Has Initiated SunRIZE Phase 3 Study Of RZ358 In Patients With Congenital Hyperinsulinism; The First Clinical Site Has Now Been Activated Outside US; Additional Sites Are Being Activated Over The Coming Weeks And Into The Beginning Of 2024
News
コラムTop upgrades and downgrades on 6/15: SPOT, SNOW, CLR, CMTL and more
• $アルコス・ドラドス(ARCO.US)$ : Bradesco BBI Upgrades to Outperform from Neutral - PT $12
• $アームストロング・ワールド・インダストリーズ(AWI.US)$ : Loop Capital Upgrades to Buy from Hold - PT $95
• $カレン・フロスト・バンカーズ(CFR.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $155 (from $143)
• $デジタル・リアルティー・トラスト(DLR.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $144 (from $150)
• $リバティ・メディア・コーポレーションA・リバティ・フォームラ・ワン(FWONA.US)$ : Mor...
まだコメントはありません